Lv11
20 积分 2022-09-06 加入
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
1小时前
待确认
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies
1小时前
已完结
Trop-2 Is Highly Expressed in Early Luminal-Like Breast Cancer
5天前
已完结
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer
5天前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study
19天前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
1个月前
已完结
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)
1个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
2个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
4个月前
已完结
[Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance]
4个月前
已关闭
皖公网安备34019202002308
